NeoGenomics Inc. NeoGenomics Announces Pricing on Public Offering of Common Stock

NeoGenomics, Inc.: NeoGenomics Announces Pricing on Public Offering of Common Stock

FT. MYERS, FL / ACCESSWIRE / May 21, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten public of...

More From BioPortfolio on "NeoGenomics, Inc.: NeoGenomics Announces Pricing on Public Offering of Common Stock"